Skip to main content
. 1998 Aug;42(8):2074–2083. doi: 10.1128/aac.42.8.2074

TABLE 2.

MICs of β-lactams for P. aeruginosa Mus, E. coli JM109 harboring recombinant plasmid pPL10, and reference strain E. coli JM109

Antibiotic(s) MIC (μg/ml) for:
P. aeruginosa Musa E. coli JM109(pPL10)b E. coli JM109
Amoxicillin >512 512 2
Amoxicillin-Clac >512 32 2
Ticarcillin 256 512 2
Ticarcillin-Cla 64 32 1
Piperacillin 64 4 1
Piperacillin-Cla 32 1 0.5
Cephalothin >1,024 32 4
Cephalothin-Cla >512 8 2
Cefamandole >512 8 1
Cefamandole-Cla >512 2 1
Cefoxitin >1,024 16 8
Cefoxitin-Cla >512 8 8
Ceftazidime 128 0.5 0.25
Ceftazidime-Cla 8 0.5 0.25
Cefotaxime 128 0.06 0.06
Cefotaxime-Cla 8 0.06 0.06
Cefepime 16 0.12 0.06
Cefepime-Cla 4 0.03 0.06
Cefpirome 32 0.5 0.12
Cefpirome-Cla 8 0.06 0.06
Moxalactam 64 0.25 0.25
Moxalactam-Cla 64 0.12 0.12
Aztreonam 256 0.25 0.12
Aztreonam-Cla 16 0.12 0.06
Imipenem 8 0.25 0.06
Imipenem-Cla 8 0.25 0.06
a

P. aeruginosa Mus produces the restricted-spectrum β-lactamase OXA-20 along with an extended spectrum β-lactamase OXA-18 and an undetermined cephalosporinase. 

b

E. coli JM109 harboring recombinant plasmid pPL10 produced the studied β-lactamase. 

c

Cla, clavulanic acid at a fixed concentration of 2 μg/ml.